Shaping the bacterial envelope: Interplay between the components and impact on antibiotic resistance
Shape-En-Resist aims to uncover the interactions and coordination mechanisms between Gram-negative bacterial envelope components to understand their role in antibiotic resistance and bacterial physiology.
Projectdetails
Introduction
Gram-negative bacteria are notoriously resilient, dominating the list of pathogens requiring urgent medical attention. Fundamental to their remarkable antibiotic resistance is a tripartite envelope comprised of an inner membrane (IM), peptidoglycan cell wall (PG), and an outer membrane (OM). While these layers were previously viewed as separate compartments, it is becoming apparent that they work together in order to maintain envelope integrity.
Research Gap
However, little is known about the crosstalk between components and the molecular mechanisms orchestrating envelope assembly and functionality. Our latest work has identified a key interaction between the PG and the BAM complex, which inserts new OM proteins (OMPs), revealing a mechanism coordinating PG and OMP biogenesis and directing them both to the cell center.
Hypothesis
We posit that coordination is a key principle of envelope assembly and that multiple interactions among envelope constituents are waiting to be discovered.
Project Goals
In Shape-En-Resist, we will uncover novel physical and genetic interactions, identify coordination mechanisms, and elucidate their impact on bacterial physiology and antibiotic resistance. To this end, we will focus on three aims:
- Explore the assembly of lipopolysaccharide (LPS), an endotoxin covering the bacterial surface, and characterize its interplay with envelope biogenesis.
- Comprehensively map PG-OMP interactions and study how they affect bacterial response to antibiotics.
- Uncover the outcomes of spatially heterogeneous envelope biogenesis and whether this process is a source of phenotypic diversity.
Methodology
To address these questions, a multidisciplinary approach will be taken, combining cutting-edge microscopy, advanced genetic screens, proteomics, and novel functionality assays.
Expected Outcomes
We expect this project to uncover the interaction network amongst envelope components, reveal how it impacts the physiology of both single cells and bacterial populations, and ultimately expose the secrets of bacterial resilience.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.894 |
Totale projectbegroting | € 1.499.894 |
Tijdlijn
Startdatum | 1-1-2025 |
Einddatum | 31-12-2029 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- THE HEBREW UNIVERSITY OF JERUSALEMpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Breaking down barriers against antimicrobials: elucidating a cross-kingdom novel lipid transport mechanismThis project aims to characterize DedA proteins to uncover their role in lipid transport and cell envelope biogenesis in Gram-negative bacteria, addressing antimicrobial resistance mechanisms. | ERC Starting... | € 1.472.710 | 2025 | Details |
Breaking resistance of pathogenic bacteria by chemical dysregulationThe project aims to combat antibiotic-resistant bacteria by developing innovative small molecules that dysregulate bacterial physiology through a three-tiered chemical strategy. | ERC Advanced... | € 2.499.785 | 2023 | Details |
Structure and Regulation of Bacterial Biofilm-Promoting Exopolysaccharide Secretion SystemsThe project aims to decode the assembly and function of exopolysaccharide secretion systems in bacteria to develop novel anti-infectives and enhance beneficial EPS production. | ERC Consolid... | € 1.950.000 | 2024 | Details |
Physical and molecular underpinnings of the multifunctionality of bacterial peptide assembliesThis project aims to uncover the self-assembly mechanisms of phenol soluble modulins in Staphylococcus aureus to understand their multifunctionality and develop novel therapeutics against infections. | ERC Starting... | € 1.500.000 | 2025 | Details |
Determining the mechanisms of lipid-targeting antibiotics in intact bacteriaThis project aims to elucidate the mechanisms of lipid-targeting antibiotics using advanced imaging and NMR techniques to combat antimicrobial resistance effectively. | ERC Consolid... | € 2.000.000 | 2022 | Details |
Breaking down barriers against antimicrobials: elucidating a cross-kingdom novel lipid transport mechanism
This project aims to characterize DedA proteins to uncover their role in lipid transport and cell envelope biogenesis in Gram-negative bacteria, addressing antimicrobial resistance mechanisms.
Breaking resistance of pathogenic bacteria by chemical dysregulation
The project aims to combat antibiotic-resistant bacteria by developing innovative small molecules that dysregulate bacterial physiology through a three-tiered chemical strategy.
Structure and Regulation of Bacterial Biofilm-Promoting Exopolysaccharide Secretion Systems
The project aims to decode the assembly and function of exopolysaccharide secretion systems in bacteria to develop novel anti-infectives and enhance beneficial EPS production.
Physical and molecular underpinnings of the multifunctionality of bacterial peptide assemblies
This project aims to uncover the self-assembly mechanisms of phenol soluble modulins in Staphylococcus aureus to understand their multifunctionality and develop novel therapeutics against infections.
Determining the mechanisms of lipid-targeting antibiotics in intact bacteria
This project aims to elucidate the mechanisms of lipid-targeting antibiotics using advanced imaging and NMR techniques to combat antimicrobial resistance effectively.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Pharmaco-modulation of epithelia for induction of antimicrobial peptide expression: a disruptive approach to fight antibiotic resistanceMaxImmun aims to develop innovative molecules that enhance antimicrobial peptides to combat infections and antibiotic resistance, progressing towards clinical trials. | EIC Pathfinder | € 3.194.450 | 2024 | Details |
Pharmaco-modulation of epithelia for induction of antimicrobial peptide expression: a disruptive approach to fight antibiotic resistance
MaxImmun aims to develop innovative molecules that enhance antimicrobial peptides to combat infections and antibiotic resistance, progressing towards clinical trials.